Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer

NCT01383863 ·Status: COMPLETED

Phase II Study of ASP3550 in Patients With Prostate Cancer

NCT00568516 ·Status: COMPLETED ·Phase: PHASE2

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

NCT06500741 ·Status: COMPLETED

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

NCT00027859 ·Status: COMPLETED ·Phase: PHASE3

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer

NCT02175212 ·Status: COMPLETED ·Phase: PHASE3

PROCARE - PROstate Cancer Real World Evidence Registry

NCT06835218 ·Status: RECRUITING

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

NCT00502164 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure

NCT00038662 ·Status: COMPLETED ·Phase: PHASE2

Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients

NCT03336983 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC

NCT00286793 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparison of Bone Mineral Loss in Prostate Cancer Patients Who is Receiving GnRH Agonist and -Plus Anti-androgen Agent

NCT01303692 ·Status: COMPLETED

A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death

NCT03619980 ·Status: COMPLETED

Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers

NCT00223171 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

NCT00036543 ·Status: COMPLETED ·Phase: PHASE3

Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy

NCT02121639 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

NCT06652607 ·Status: RECRUITING

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

NCT01313273 ·Status: TERMINATED ·Phase: PHASE3

Open Label Trial to Assess Iressa in Prostate Cancer Patients

NCT00635856 ·Status: COMPLETED ·Phase: PHASE2

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

NCT00075192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

NCT00003645 ·Status: TERMINATED ·Phase: PHASE3

A Long Term Safety Study With Atrasentan

NCT00127478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Depiction of Prostate Cancer Treatment Alternatives in Greece

NCT00733213 ·Status: COMPLETED

Atrasentan in Treating Patients With Prostate Cancer

NCT00046943 ·Status: COMPLETED ·Phase: PHASE3